This is a non-core endpoint: only basic statistics are computed.
Melanoma in situ of lower limb, including hip
CD2_INSITU_MELANOMA_LOWERLIMB_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D03
- Name in latin
- Melanoma in situ coxae
Similar endpoints
↥List of similar endpoints to
Melanoma in situ of lower limb, including hip
based on the number of shared cases.
Similar with more cases:
- Melanoma in situ of lower limb, including hip
- Melanoma in situ
- Melanoma in situ
- Malignant melanoma
- Malignant melanoma, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 200 | 152 | 48 |
| Unadjusted period prevalence (%) | 0.04 | 0.05 | 0.02 |
| Median age at first event (years) | 64.05 | 62.01 | 70.52 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 173
- Matched controls
- 1729
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D03.7
ICD-10 Finland
Melanoma in situ of lower limb, including hip
+∞
250.2
173
*
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
259.0
123.2
115
13
8720/2-C44.9
ICD-O-3
Melanoma in situ of skin, NOS
+∞
47.0
43
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
18.1
41.8
69
61
D22.7
ICD-10 Finland
Melanocytic naevi of lower limb, including hip
75.9
37.1
41
7
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
21.6
32.2
48
30
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
23.6
31.9
46
26
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
18.5
31.6
50
37
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
25.6
24
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
263.1
23.2
23
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
131.6
22.1
23
*
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
15.3
21.6
36
29
R23.8
ICD-10 Finland
Other and unspecified skin changes
6.6
20.9
61
132
C43.72
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type
224.4
20.0
20
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
18.0
17
*
C43.70
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip without histology
+∞
18.0
17
*
D22
ICD-10 Finland
Melanocytic naevi
16.4
17.5
28
20
L57.0
ICD-10 Finland
Actinic keratosis
7.6
16.6
41
68
8720/3-C44.7
ICD-O-3
Malignant melanoma, NOS, of skin of lower limb and hip
+∞
15.9
15
*
C43.79
ICD-10 Finland
Malignant melanoma of the lower extremity including hip or other unspecified histology
+∞
15.9
15
*
S18
ICPC
Laceration/cut
3.7
15.3
105
506
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
20.8
15.1
22
12
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
14.8
14
*
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
14.8
14
*
QDE99
NOMESCO Finland
Other excision or repair of lesion of skin of lower limb
81.3
13.8
15
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
8.1
13.6
31
45
ZZR00
NOMESCO Finland
Flap of skin
75.5
12.8
14
*
ZZA00
NOMESCO Finland
Split skin graft
13.9
12.5
21
17
S77
ICPC
Malignant neoplasm of skin
69.7
11.8
13
*
115
Kela drug reimbursment
Breast cancer
+∞
11.6
11
*
XQ846
NOMESCO Finland
Digital dermatoscopy and registration of nevi
+∞
11.6
11
*
C43.7
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of lower limb, including hip
+∞
11.6
11
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
11.6
11
*
D03.5
ICD-10 Finland
Melanoma in situ of trunk
128.0
11.6
12
*
TQW99
NOMESCO Finland
Other minor procedure on skin
8.4
10.6
23
31
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
+∞
10.5
10
*
L82
ICD-10 Finland
Seborrhoeic keratosis
3.8
9.7
45
147
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
23.2
9.5
13
6
130
Kela drug reimbursment
Malignant tumour
+∞
9.5
9
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
9.5
9
*
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
+∞
9.5
9
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
9.5
9
*
HAC20
NOMESCO Finland
Total mastectomy
94.4
8.5
9
*
C43
ICD-10 Finland
Malignant melanoma of skin
+∞
8.4
8
*
8090/3-C44.7
ICD-O-3
Basal cell carcinoma, NOS, of skin of lower limb and hip
+∞
8.4
8
*
8720/2-C44.7
ICD-O-3
Melanoma in situ of skin of lower limb and hip
+∞
8.4
8
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
8.4
8
*
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
8.4
8
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
8.4
8
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
8.4
8
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
8.4
8
*
C43.73
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip nodular
+∞
8.4
8
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
8.4
8
*
JN4BD
NOMESCO Finland
Extensive body CT
6.1
8.0
21
38
ZXC20
NOMESCO Finland
Use of chemical agents
26.3
7.7
10
*
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
26.3
7.7
10
*
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
26.3
7.7
10
*
ZXC50
NOMESCO Finland
Cryotherapy
14.2
7.5
12
9
C61
ICD-10 Finland
Malignant neoplasm of prostate
83.4
7.5
8
*
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
+∞
7.3
7
*
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
+∞
7.3
7
*
8742/2-C44.9
ICD-O-3
Lentigo maligna of skin, NOS
+∞
7.3
7
*
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
7.3
7
*
JN4AD
NOMESCO Finland
Body CT examination
8.5
7.3
15
19
S82
ICPC
Naevus/mole
3.4
7.1
35
119
XQ848
NOMESCO Finland
Dermatological photography
9.9
6.9
13
14
SPAT1153
SPAT
Removal of sutures
2.4
6.5
71
388
D03.6
ICD-10 Finland
Melanoma in situ of upper limb, including shoulder
72.3
6.5
7
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
72.3
6.5
7
*
D06BB10
ATC
imiquimod; topical
6.7
6.3
15
24
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
6.3
6
*
C43.71
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip originating in lentigo maligna
+∞
6.3
6
*
H02AB02
ATC
dexamethasone; systemic
10.6
6.1
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3002256) Pathology report gross observation
111
118
19.89
104.44
1.9
1.1
—
—
—
0
0
(4035726)
60
52
16.05
61.44
1.5
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
174
569
16.83
61.27
4.3
1.7
—
—
—
0
0
(40768443) Skin Pathology biopsy report
32
73
5.03
13.65
1.6
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
13
18
7.65
8.95
1.3
1.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
123
869
2.08
5.84
9.8
6.5
e9/l
3.9
4.1
0.48
109
757
(42870588) Differential panel, method unspecified - Blood
80
499
2.01
5.22
8.9
5.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
11
24
4.79
4.84
1.5
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
11
24
4.79
4.84
1.5
1.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
10
20
5.21
4.83
1.2
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
183
1595
2.73
4.07
17.3
10.4
ml/min/173m2
77.9
77.9
0.02
152
1273
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
43
232
2.09
4.06
2.3
2.8
e6/l
1.5
2.6
0.72
20
114
(3013115) Eosinophils [#/volume] in Blood
111
821
1.79
3.96
8.6
5.6
e9/l
0.2
0.2
0.19
100
721
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
45
257
1.97
3.62
2.6
2.5
e6/l
0.4
1.1
2.10
22
137
(3000494) Fungus identified in Specimen by Culture
38
205
2.05
3.57
1.4
1.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
11
31
3.70
3.53
1.3
1.5
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
17
65
2.77
3.40
3.4
7.4
mmol/l
23.7
25.0
1.50
17
59
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
194
1802
3.55
3.31
12.5
8.7
u/l
24.5
24.3
0.10
188
1721
(3018418) pH of Serum or Plasma
69
464
1.74
3.28
3.5
2.9
ph
7.4
7.4
0.32
13
60
(3001604) Monocytes [#/volume] in Blood
105
792
1.69
3.27
8.4
5.0
e9/l
0.6
0.6
0.78
94
688
(3019198) Lymphocytes [#/volume] in Blood
106
803
1.68
3.24
8.4
5.2
e9/l
1.9
1.9
0.07
96
706
(3024891) Influenza virus A+B Ag [Presence] in Specimen
11
33
3.47
3.24
1.2
1.1
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
95
701
1.68
3.20
4.8
4.7
mmol/l
1.2
1.2
0.54
89
627
(3006315) Basophils [#/volume] in Blood
105
796
1.67
3.18
8.5
5.0
e9/l
0.0
0.0
0.55
94
688
(40758558) Short blood count panel - Blood
54
345
1.77
3.04
8.5
4.8
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
36
202
1.95
3.03
2.5
2.2
mmol/l
0.8
0.8
0.17
36
187
(36304419) Bacteria [Presence] in Urine
59
389
1.73
2.97
3.5
2.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
63
425
1.70
2.92
2.3
1.9
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
28
147
2.05
2.83
1.6
1.8
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
5
6
8.50
2.76
1.2
1.0
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
7
14
5.14
2.75
1.9
1.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
36
209
1.88
2.74
1.8
1.7
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
102
788
1.60
2.73
4.8
5.0
mmol/l
1.2
1.2
1.17
90
686
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
147
1242
1.69
2.73
9.1
5.0
u/l
74.6
75.3
0.13
141
1133
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
8
19
4.34
2.70
1.1
1.5
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
18
80
2.37
2.70
4.2
1.6
u/ml
19.7
30.1
0.36
18
75
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
37
219
1.85
2.65
1.6
1.8
—
—
—
0
0
(3022145) Colonoscopy Study observation
31
174
1.92
2.61
1.7
1.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
50
326
1.71
2.59
2.2
1.9
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
97
747
1.58
2.59
9.5
5.4
%
27.1
28.5
0.66
91
685
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
18
82
2.31
2.56
1.4
1.7
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
72
519
1.61
2.53
1.9
2.0
u/l
327.3
282.6
0.07
66
483
(3018405) Lactate [Moles/volume] in Arterial blood
0
63
0.00
2.47
0.0
4.8
—
1.3
—
0
63
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
92
706
1.56
2.46
2.3
2.3
nmol/l
85.6
79.1
1.48
86
618
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
27
148
1.95
2.43
1.6
1.9
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
59
411
1.62
2.36
3.5
2.7
e6/l
0.4
0.4
0.08
41
297
(3002582) Erythrocytes [#/volume] in Urine
63
447
1.60
2.34
3.1
2.7
e6/l
9.9
199.4
0.69
45
333
(3018095) Leukocytes [#/volume] in Urine
73
541
1.55
2.24
3.8
3.4
e6/l
27.3
129.7
2.73
47
363
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
14
61
2.39
2.20
4.4
8.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
7
20
3.59
2.07
1.1
1.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
11
44
2.59
2.05
1.4
1.1
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
71
533
1.51
2.02
3.3
2.8
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
29
175
1.77
1.96
3.7
2.5
ug/l
0.8
0.7
0.29
21
116
(3003694) ABO and Rh group [Type] in Blood
51
358
1.57
1.95
1.5
1.3
—
—
—
0
0
(4281824)
5
11
4.63
1.95
1.2
1.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
11
4.63
1.95
1.4
1.3
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
68
514
1.49
1.85
4.3
2.0
mmol/l
2.3
2.4
0.51
60
422
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
84
666
1.45
1.78
3.5
3.5
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
15
75
2.08
1.74
4.7
5.3
mmol/l
24.5
25.1
0.31
15
75
(3021589) Normoblasts [#/volume] in Blood
86
691
1.43
1.68
12.4
7.7
e9/l
0.0
0.0
0.47
69
569
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
179
1658
1.76
1.67
16.9
11.5
mg/l
23.6
19.6
0.73
139
1238
(1616796) Gas panel - Central venous blood
7
25
2.86
1.66
3.1
1.8
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5
15
3.39
1.53
1.8
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
12
58
2.14
1.52
1.2
1.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
27
173
1.65
1.50
1.7
1.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
9
38
2.43
1.47
1.9
1.8
—
—
—
0
0
(3000492) Spirometry study
22
134
1.72
1.46
1.6
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
17
96
1.84
1.44
1.2
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
186
1755
1.85
1.43
4.8
5.3
mmol/l
2.7
2.8
0.77
172
1612
(42529406) Shigella sp [Presence] in Stool by Culture
12
60
2.06
1.41
1.2
1.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
50
374
1.45
1.40
4.9
3.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
9
41
2.25
1.39
1.6
1.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
18
105
1.78
1.38
4.6
6.6
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
6
23
2.66
1.38
1.2
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
49
367
1.44
1.37
4.1
1.7
mg/l
5.6
1.0
0.56
35
288
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
183
1723
1.73
1.35
4.1
4.7
mmol/l
4.6
4.7
0.94
171
1594
(3009542) Hematocrit [Volume Fraction] of Blood
163
1498
1.48
1.32
20.0
13.1
%
40.3
39.7
0.80
118
1037
(3014111) Lactate [Moles/volume] in Serum or Plasma
19
115
1.72
1.30
4.6
5.1
mmol/l
1.2
1.4
0.40
19
109
(3000850) Epithelial cells [#/volume] in Urine
41
300
1.46
1.29
2.9
2.1
e6/l
2.7
6.2
2.97
35
261
(3020564) Creatinine [Moles/volume] in Serum or Plasma
188
1789
1.85
1.25
18.9
13.4
umol/l
76.2
74.9
0.27
188
1789
(3021960) Folate [Moles/volume] in Serum or Plasma
54
419
1.40
1.24
1.6
1.5
nmol/l
25.6
21.7
1.01
47
369
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
22
141
1.63
1.23
3.7
3.0
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
48
365
1.41
1.23
4.3
3.8
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
33
234
1.49
1.21
2.9
2.3
umol/l
12.9
13.8
0.31
27
212
(3004789) Transferrin [Mass/volume] in Serum or Plasma
29
200
1.53
1.21
3.0
2.3
g/l
2.1
2.4
1.64
24
185
(3037467) Urinalysis macro (dipstick) panel - Urine
127
1128
1.34
1.20
5.3
4.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
110
957
1.33
1.20
2.7
2.8
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
6
26
2.35
1.19
1.7
1.1
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
11
57
1.98
1.19
4.4
1.8
ug/l
592.2
965.5
0.17
11
50
(3041354) Potassium [Moles/volume] in Venous blood
0
33
0.00
1.17
0.0
2.2
—
4.1
—
0
33
(3035285) Chloride [Moles/volume] in Venous blood
0
33
0.00
1.17
0.0
2.2
—
106.2
—
0
33
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
33
0.00
1.17
0.0
2.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
181
1711
1.61
1.16
4.6
4.7
mmol/l
5.7
5.9
3.61
167
1561
(3045424) Erythrocytes [Presence] in Urine
5
20
2.54
1.16
1.4
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
36
0.00
1.15
0.0
1.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
15
88
1.76
1.15
2.2
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
11
58
1.95
1.14
1.1
1.2
—
—
—
0
0
(3026782) Osmolality of Urine
39
291
1.42
1.11
2.4
2.4
mosm/kgh2o
583.7
525.6
0.69
31
238
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
5
21
2.42
1.09
1.6
1.2
u/l
51.2
42.4
—
5
16
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
24
163
1.54
1.08
1.4
2.1
umol/l
4.7
5.5
0.65
18
139
(3026493) Urate [Moles/volume] in Serum or Plasma
52
413
1.35
1.03
2.4
2.2
umol/l
353.7
8647.4
2.46
46
355
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
118
1051
1.30
1.02
3.3
2.9
u/l
38.3
43.5
0.52
107
973
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
30
217
1.45
1.01
4.0
4.9
%
33.0
33.7
0.15
22
134
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
7
35
2.04
1.01
1.1
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
23
2.20
0.98
1.0
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
5
23
2.20
0.98
5.8
2.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
180
1711
1.52
0.98
4.1
4.7
mmol/l
1.6
1.5
0.11
168
1575
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
6
27
2.26
0.94
1.2
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
19
127
1.55
0.92
1.7
1.8
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
6
28
2.18
0.92
4.3
2.0
kpa
5.3
5.0
—
6
28
(3027315) Oxygen [Partial pressure] in Blood
6
28
2.18
0.92
4.3
2.0
kpa
8.0
8.3
—
6
28
(3012501) Base excess in Blood by calculation
6
28
2.18
0.92
4.3
2.0
mmol/l
-0.2
3.0
—
6
13
(3021879) Hepatitis B virus core Ab [Presence] in Serum
12
71
1.73
0.91
1.4
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
22
153
1.49
0.90
2.0
1.4
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
6
29
2.10
0.90
1.7
1.1
—
—
—
0
0
(4010399)
19
128
1.54
0.90
1.5
1.4
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
15
96
1.61
0.87
1.3
1.2
u/ml
282.8
189.8
0.17
15
88
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
62
519
1.28
0.84
2.6
2.6
u/l
26.8
30.3
0.74
55
491
(3013707) Erythrocyte sedimentation rate by Westergren method
139
1281
1.28
0.84
4.8
4.2
mm/h
9.6
12.2
2.35
127
1165
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
171
1621
1.38
0.83
5.5
6.0
mmol/mol
38.5
39.9
1.70
157
1511
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
54
644
0.78
0.81
3.7
3.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
26
192
1.41
0.80
2.0
1.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
0
24
0.00
0.79
0.0
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
6
33
1.84
0.79
3.7
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
0
25
0.00
0.79
0.0
3.0
—
24.3
—
0
6
(3017143) Hepatitis C virus Ab [Presence] in Serum
19
132
1.49
0.79
2.3
1.5
—
—
—
0
0
(3012544) pH of Venous blood
10
160
0.61
0.77
3.7
3.3
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
28
0.00
0.76
0.0
1.3
—
7.7
—
0
16
(3013826) Glucose [Moles/volume] in Serum or Plasma
103
924
1.24
0.76
4.0
3.9
mmol/l
6.4
6.7
0.78
93
854
(3030905) Polymorphonuclear cells [#/volume] in Blood
5
24
2.11
0.75
3.0
2.1
e9/l
4.8
4.7
—
5
24
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
5
24
2.11
0.75
3.0
2.8
%
63.8
61.7
—
5
24
(3045414) Leukocytes [Presence] in Urine
9
55
1.67
0.74
1.4
1.8
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
17
117
1.50
0.74
3.8
3.0
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
16
109
1.51
0.73
1.6
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
5
25
2.02
0.73
1.0
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
25
327
0.73
0.72
1.3
1.3
u/ml
10.9
15.1
—
10
116
(3022313) Gas panel - Capillary blood
9
57
1.61
0.72
2.3
5.1
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
22
161
1.41
0.72
3.4
6.4
kpa
11.7
11.5
0.08
22
156
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
22
161
1.41
0.72
3.4
6.4
kpa
5.1
5.2
0.14
22
156
(3048929) Epstein Barr virus Ab [Presence] in Serum
5
27
1.87
0.69
2.0
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
5
92
0.53
0.69
2.8
5.6
—
—
—
0
0
(3019225) pH of Specimen
21
154
1.41
0.68
4.0
3.7
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
13
86
1.55
0.68
1.1
1.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
31
244
1.32
0.66
4.6
3.7
%
20.7
23.4
0.58
19
117
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
5
29
1.74
0.64
1.8
1.1
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
10
152
0.64
0.64
3.5
3.2
kpa
6.0
5.8
—
10
147
(3004716) Salmonella sp identified in Stool by Organism specific culture
13
88
1.51
0.62
1.2
1.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
26
202
1.33
0.61
2.4
2.2
ug/g
78.9
127.5
0.87
15
160
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
20
263
0.73
0.61
2.2
1.4
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
17
124
1.41
0.58
1.8
2.3
e9/l
67.1
67.6
—
7
101
(3013512) EKG study
58
506
1.21
0.54
3.3
3.7
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
9
63
1.45
0.53
1.3
1.5
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
70
623
1.19
0.52
10.2
9.4
inr
1.2
1.3
0.28
23
166
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
58
657
0.83
0.52
2.8
3.6
ng/l
30.7
89.3
0.54
37
458
(1761868) Lipid panel - Serum or Plasma
66
585
1.19
0.52
2.5
3.1
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
9
65
1.40
0.51
1.0
1.1
—
6.2
—
0
5
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
14
101
1.42
0.51
1.5
1.5
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
12
84
1.46
0.50
4.3
7.8
%
93.7
93.6
0.02
12
84
(3003338) MCHC [Mass/volume]
137
1442
0.84
0.50
22.3
15.5
g/l
329.9
331.3
1.08
137
1435
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
7
45
1.58
0.49
1.7
1.3
pmol/l
59.4
59.2
—
7
45
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
7
47
1.51
0.48
1.0
1.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
37
314
1.22
0.45
6.6
3.8
ug/l
2.9
2.0
1.19
32
283
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
7
50
1.41
0.45
1.7
2.8
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
9
127
0.70
0.45
1.6
1.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
7
51
1.39
0.44
2.3
3.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
79
720
1.16
0.44
2.1
2.0
pmol/l
95.4
99.4
0.26
34
356
(40761535) Cells panel - Urine sediment
10
139
0.70
0.43
4.8
2.9
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
5
32
1.58
0.42
3.4
2.9
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
36
308
1.21
0.41
1.2
1.3
g/l
2.3
2.4
0.20
14
169
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
12
88
1.39
0.41
4.1
7.5
%
1.0
1.5
1.58
12
88
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
12
88
1.39
0.41
4.3
7.4
%
0.5
0.7
1.42
12
88
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
8
60
1.35
0.41
1.5
1.7
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
5
34
1.48
0.40
1.4
2.1
mmol/l
24.4
24.5
—
5
27
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
28
332
0.82
0.40
1.4
1.3
iu/ml
45.4
39.9
—
8
106
(3040151) Glucose [Moles/volume] in Capillary blood
0
19
0.00
0.39
0.0
4.5
—
6.6
—
0
13
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
19
0.00
0.39
0.0
2.9
—
13.5
—
0
19
(3023323) Follitropin [Units/volume] in Serum or Plasma
9
66
1.38
0.39
1.0
1.2
iu/l
27.4
26.5
—
9
59
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
167
1617
1.20
0.38
5.3
4.9
mu/l
1.9
1.9
0.17
159
1475
(3014576) Chloride [Moles/volume] in Serum or Plasma
22
180
1.25
0.38
4.1
5.2
mmol/l
104.3
104.1
0.09
22
175
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
9
70
1.30
0.37
1.0
1.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
79
728
1.14
0.37
2.8
2.7
ug/l
130.6
97.1
0.95
73
672
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
26
219
1.22
0.35
4.8
6.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
39
342
1.17
0.35
3.2
3.6
ng/l
65.2
174.0
0.52
29
257
(3021601) Nitrite [Presence] in Urine by Test strip
88
820
1.13
0.34
4.7
5.0
estimate
0.0
0.0
0.00
14
129
(3000330) Specific gravity of Urine by Test strip
6
90
0.66
0.33
1.7
3.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
143
1375
1.14
0.33
4.3
4.0
pmol/l
15.0
14.8
0.46
135
1256
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
169
1644
1.18
0.32
3.8
4.2
mmol/l
1.3
1.3
0.29
155
1501
(3003327) Ova and parasites identified in Stool by Light microscopy
7
57
1.24
0.29
2.4
1.5
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
8
66
1.22
0.27
1.4
1.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
88
833
1.10
0.24
3.3
3.6
estimate
0.0
0.0
0.00
15
127
(40761511) CBC panel - Blood by Automated count
178
1747
1.17
0.24
13.5
11.3
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
43
393
1.12
0.23
2.7
2.2
mg/l
2.4
3.2
1.92
37
333
(3016038) Potassium [Moles/volume] in Urine
0
11
0.00
0.21
0.0
1.0
—
28.5
—
0
11
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
10
0.00
0.21
0.0
1.1
—
5.9
—
0
10
(44806420)
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.2
—
22.7
—
0
10
(3045716) Anion gap in Serum or Plasma
0
10
0.00
0.21
0.0
1.5
—
9.2
—
0
10
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
54
502
1.10
0.21
1.5
1.7
mmol/l
1.5
1.3
0.47
47
433
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
0
12
0.00
0.21
0.0
1.3
—
1.7
—
0
7
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
13
0.00
0.21
0.0
1.7
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
13
0.00
0.21
0.0
2.3
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.2
—
1.8
—
0
13
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
14
0.00
0.20
0.0
1.9
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
49
524
0.91
0.18
4.0
3.0
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
85
814
1.08
0.17
3.4
3.6
estimate
0.0
0.0
0.00
15
133
(3012516) Albumin [Mass/volume] in Urine
57
538
1.08
0.16
2.8
3.0
mg/l
10.7
170.4
0.68
33
324
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
7
87
0.80
0.15
2.7
2.2
%
1.6
1.0
—
7
87
(3015736) pH of Urine
63
661
0.93
0.15
3.6
3.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
14
122
1.16
0.14
1.3
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
9
107
0.83
0.13
1.3
2.8
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
43
455
0.93
0.12
2.6
3.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
33
311
1.07
0.10
1.3
1.4
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
5
48
1.04
0.09
1.0
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
6
57
1.05
0.08
1.5
1.6
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
38
363
1.06
0.08
1.2
1.3
u/ml
2.4
1.8
—
9
99
(3044889) 12 lead EKG panel
119
1210
0.96
0.07
4.0
3.8
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
8
75
1.07
0.07
2.1
1.9
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
8
78
1.03
0.07
2.4
1.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
34
325
1.06
0.06
1.8
1.7
nmol/l
1238.2
1211.7
0.04
19
241
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
12
109
1.11
0.06
1.4
1.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
10
92
1.09
0.03
1.1
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
11
102
1.08
0.03
2.3
2.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
57
560
1.02
0.02
2.7
2.9
mmol/l
6.8
7.1
0.18
47
464
(3020682) Albumin/Creatinine [Ratio] in Urine
56
569
0.98
0.02
3.8
3.8
mg/mmol
1.9
6.7
2.29
32
337
(3011397) Hemoglobin [Presence] in Urine by Test strip
39
383
1.02
0.01
4.2
3.5
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
12
126
0.95
0.00
1.0
1.2
iu/ml
82.2
116.9
—
6
59
(40768797) Stomach Pathology biopsy report
24
246
0.97
0.00
1.3
1.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
52
514
1.02
0.00
4.2
2.9
ng/l
1119.4
1142.0
0.03
44
432
(36660697) Celiac disease serology panel - Serum
13
126
1.03
0.00
1.1
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
43
427
1.01
0.00
3.9
3.7
estimate
0.0
0.0
0.00
13
126
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
37
365
1.02
0.00
1.6
1.7
pmol/l
526.2
455.6
0.67
32
303
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
12
122
0.98
0.00
1.7
1.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
18
178
1.01
0.00
1.9
1.5
—
—
—
0
0
(3017704) Immunofixation for Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
30.0
—
0
7
(21491868) Cryoglobulin [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(4198724)
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
7
0.00
0.00
0.0
6.4
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
23.7
—
0
5
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
211.2
—
0
5
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004451) EKG impression Narrative
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
11
110
1.00
0.00
1.5
1.6
—
—
—
0
0
(1002224) Polysomnography panel
6
63
0.95
0.00
1.0
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
64
0.94
0.00
2.2
1.5
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(4211845)
0
9
0.00
0.00
0.0
5.2
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_MELANOMA_LOWERLIMB_EXALLC – Melanoma in situ of lower limb, including hip
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).